Inhibitory effects of okadaic acid on rat uterine contractile responses to different spasmogens

Fundam Clin Pharmacol. 1997;11(1):47-56. doi: 10.1111/j.1472-8206.1997.tb00168.x.

Abstract

In the present study, we examined the effects of okadaic acid, a selective inhibitor of type 1 and 2A protein phosphatases, on the mechanical responses evoked by oxytocin, K(+)- and Na(+)-modified solutions and ouabain in estrogen-primed rat myometrium. Oxytocin elicited a rapid, phasic contraction followed by rhythmic oscillations. The phasic response was partially resistant to the absence of external Ca2+. Okadaic acid (1 microM) and the L-type calcium channel blocker nifedipine (1 microM) abolished the oscillatory component and reduced the initial, phasic response to about 80% of the control response. High K+ (60 mM) solution, ouabain (1 mM), K(+)-free medium and low Na+ (25 mM) solution induced extracellular Ca(2+)-dependent biphasic responses composed by an early rapid (KCl, ouabain and K(+)-free solution) or slower developed (25 mM Na+ solution) phasic contraction followed by a sustained increase in tension. Okadaic acid and nifedipine, alone or in combination, abolished or decreased similarly the contractile response evoked by these stimulants. The okadaic acid- and nifedipine-insensitive responses to ouabain, K(+)-free and low Na+ solution were enhanced by increasing the extracellular concentration of Ca2+ in the medium and were inhibited in a dose-dependent manner by amiloride (0.05-0.5 mM). These data suggest that, in estrogen-primed rat uterus, dephosphorylating mechanisms by OA-sensitive protein phosphatases play an important role in regulating myometrial contractions elicited by Ca2+ entry through voltage-sensitive Ca2+ channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / pharmacology
  • Calcium Channel Blockers / pharmacology*
  • Dose-Response Relationship, Drug
  • Female
  • Nifedipine / pharmacology*
  • Okadaic Acid / pharmacology*
  • Ouabain / pharmacology
  • Oxytocin / pharmacology
  • Phosphoric Monoester Hydrolases / antagonists & inhibitors*
  • Potassium / antagonists & inhibitors
  • Rats
  • Rats, Wistar
  • Sodium / pharmacology
  • Uterine Contraction / drug effects*
  • Uterine Contraction / physiology

Substances

  • Calcium Channel Blockers
  • Okadaic Acid
  • Oxytocin
  • Ouabain
  • Sodium
  • Phosphoric Monoester Hydrolases
  • Nifedipine
  • Potassium
  • Calcium